Skip to main content
. 2020 May 25;10:2045125320926347. doi: 10.1177/2045125320926347

Table 5.

Change in PSP Scale total and subscale scores (mITT efficacy analysis set).

Characteristic Total (n = 294) Achieved SR at LOCF endpoint (n = 166) Did not achieve SR at LOCF endpoint (n = 128)
PSP total score
 Baseline 65.85 (14.03) 70.42 (10.95) 59.94 (15.35)
 LOCF endpoint 66.89 (14.28) 72.36 (10.33) 59.80 (15.55)
 Mean change from baseline (95% CI) 1.04 (–0.3, 2.3) 1.95 (0.5, 3.4) −0.14 (–2.5, 2.2)
Social useful activities
 Baseline 2.62 (1.13) 2.28 (0.91) 3.07 (1.22)
 LOCF endpoint 2.59 (1.01) 2.19 (0.78) 3.09 (1.06)
 Mean change from baseline (95% CI) −0.04 (–0.1, 0.1) −0.08 (–0.2, 0) 0.02 (–0.2, 0.2)
Personal and social relationships
 Baseline 2.63 (0.99) 2.37 (0.88) 2.98 (1.02)
 LOCF endpoint 2.59 (1.00) 2.20 (0.81) 3.09 (1.00)
 Mean change from baseline (95% CI) −0.04 (–0.1, 0.1) −0.16 (–0.3, 0) 0.12 (0, 0.3)
Self-care
 Baseline 1.79 (0.86) 1.58 (0.74) 2.06 (0.92)
 LOCF endpoint 1.79 (0.87) 1.61 (0.76) 2.02 (0.95)
 Mean change from baseline (95% CI) 0 (–0.1, 0.1) 0.04 (–0.1, 0.2) −0.05 (–0.2, 0.1)
Disturbing and aggressive behavior
 Baseline 1.14 (0.37) 1.13 (0.35) 1.16 (0.39)
 LOCF endpoint 1.11 (0.40) 1.04 (0.23) 1.20 (0.54)
 Mean change from baseline (95% CI) −0.03 (–0.1, 0) −0.08 (–0.1, 0) 0.05 (–0.1, 0.2)

Values are mean (standard deviation) unless otherwise indicated. Only patients with both baseline and at least one post-baseline assessment were included in the analysis.

CI, confidence interval; LOCF, last observation carried forward; mITT, modified intent-to-treat; PSP, personal and social performance; SR, symptomatic remission.